Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Professional Development

According to Reuters, GlaxoSmithKline’s experimental Ebola vaccine will be moving to the second phase of its trial and expanding to several additional countries in February 2015. Currently undergoing Phase I trials in the U.S., Switzerland, Britain...
According to The New York Times’ Well blog, a 15-year Dutch study revealed that the risks of taking a small daily dose of aspirin may outweigh the benefits. The study, published in Heart, consisted of 27,939 female subjects who were either given 100...
At Indiana University, researchers are in the process of creating a drug that will help kick obesity in the form of a simple pill, the Los Angeles Times reports. A study published in Nature Medicine describes the synthesized product consisting of gut...